|
|
 |
|
Viewing report
|
|
|
|
Vertex Pharmaceuticals, Inc.
Datamonitor, Sep 2008, Pages: 23
The Vertex Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Vertex Pharmaceuticals (Vertex) is a biotechnology company engaged in discovering, developing and commercializing small molecule drugs for the treatment of major diseases like HIV infection, hepatitis C virus infection, cancer, and inflammatory and autoimmune disorders. Vertex is headquartered in Cambridge, Massachusetts and had 1,150 full time employees as of December 31, 2007. The company recorded revenues of $199 million during the financial year (FY) ended December 2007, a decrease of 8.02% over FY2006. The decrease was primarily attributable to the expiration of the research collaboration with Novartis Pharma, together with the corresponding research funding during the second quarter of 2006; along with lower milestone payments earned from research program with Merck. The operating loss of the company was $420 million during FY2007, as compared to an operating loss of $229 million in FY2006. The net loss was $391 million in FY2007, as compared to a net loss of $207 million in FY2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Customers who bought this item also bought
Vertex Pharmaceuticals, Inc. - SWOT Analysis
Premium Company Profile Vertex Pharmaceuticals
Analysis of Vertex Pharmaceuticals
Vertex Pharmaceuticals Incorporated - Financial and Strategic Analysis Review
Vertex Pharmaceuticals - SWOT Framework Analysis
Vertex Pharmaceuticals Inc
Amylin Pharmaceuticals, Inc. - SWOT Analysis
Savient Pharmaceuticals Inc
Achillion Pharmaceuticals, Inc.
Idenix Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. - SWOT Analysis
Progenics Pharmaceuticals, Inc.
|
|
|
|
